But the really impressive numbers came from the SURPASS-5 trial, where tirzepatide reduced total cholesterol by 12.9%, LDL cholesterol by 15.5%, and triglycerides by a substantial 24.9%, while increasing HDL cholesterol by 0.9%
Tirzepatide achieved even greater results , with some trial participants losing over 20 percent of their starting weight
Compounded GLP-1 medications are not generic versions of FDA-approved drugs and are not intended to be substitutes for FDA-approved products
Monitoring your reset: what to track A GLP-1 reset without tracking is just a hope
[DOI] [PubMed] [Google Scholar] Zhou J, Montrose-Rafizadeh C, Janczewski AM, Pineyro MA, Sollott SJ, Wang Y, Egan JM
There is no conclusive evidence that semaglutide induced cancer development in tissue, which may imply that the development of cancer may pertain to other causes rather than semaglutide application [129]